Loading company…
Vitruvias Therapeutics develops and distributes generic pharmaceuticals to healthcare providers, hospitals and pharmacies in the US.
Founded in 2013 and headquartered in Auburn, US, Vitruvias Therapeutics, Inc. develops and distributes generic drugs. Its products include aminocaproic acid tablets, cyanocobalamin injection and several extended-release tablets and capsules used for bleeding disorders, vitamin deficiencies, arrhythmias, Parkinson's disease and depression. In January 2018 it raised USD 11.5 mn in a Series A round led by JW Asset Management and Perceptive Advisors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in